~~<i id='6E84EDDF36'><strike id='6E84EDDF36'><tt id='6E84EDDF36'><pre id='6E84EDDF36'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：comprehensive 2025-10-01 21:49:49 Page View：581

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide
Next article： How one medical school became remarkably diverse

leisure time

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

FILE-WorkersloadgrainatagrainportinIzmail,Ukraine,Wednesday,April26,2023.ConcernsaregrowingthatRussi

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

5:56VirginiaGovernorGlennYoungkinattendsthegrandopeningceremonyforAmazonHQ2onJune15,2023inArlington,